Bio-gate AG Total Liabilities
Bio-gate AG total liabilities. Based on the latest financial reports, Bio-gate AG (BIG1) has total liabilities worth €2.16 Million EUR (≈ $2.52 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Bio-gate AG defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Bio-gate AG (2020–2024)
Total liabilities of Bio-gate AG from 2020 to 2024. This chart illustrates how Bio-gate AG's total liabilities have evolved over time, based on quarterly financial data.
Bio-gate AG Competitors by Total Liabilities
The table below lists competitors of Bio-gate AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nordic LEVEL Group AB
ST:LEVEL
|
Sweden | Skr172.22 Million |
|
Signature Resources Ltd
V:SGU
|
Canada | CA$2.09 Million |
|
Sidomulyo Selaras Tbk
JK:SDMU
|
Indonesia | Rp116.09 Billion |
|
Nusatama Berkah Tbk PT
JK:NTBK
|
Indonesia | Rp61.05 Billion |
|
CD Private Equity Fund I
AU:CD1
|
Australia | AU$633.01K |
|
FingerMotion Inc
NASDAQ:FNGR
|
USA | $48.57 Million |
|
Nictus
JSE:NCS
|
South Africa | ZAC928.87 Million |
|
Nagreeka Exports Limited
NSE:NAGREEKEXP
|
India | Rs2.23 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Bio-gate AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Bio-gate AG assets under control.
Liquidity & Leverage Metrics
Bio-gate AG Total Liabilities Ratios Explained
Bio-gate AG total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bio-gate AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bio-gate AG (2020–2024)
The table below shows the annual total liabilities of Bio-gate AG from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €2.16 Million ≈ $2.52 Million |
+19.42% |
| 2023-12-31 | €1.81 Million ≈ $2.11 Million |
-8.07% |
| 2022-12-31 | €1.97 Million ≈ $2.30 Million |
+36.40% |
| 2021-12-31 | €1.44 Million ≈ $1.69 Million |
-18.06% |
| 2020-12-31 | €1.76 Million ≈ $2.06 Million |
-- |
About Bio-gate AG
Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating which protects the surfaces of medical implants against bacterial colonization; and MicroSilver BG, an elemental microporous silver additive. It distributes its products to veterinarians and veterinary clinics. The company was incorporated in 2005 and is bas… Read more